Corium Pharma Soloutions, LLC

Corium maintains +50 patents in the area of transdermal drug delivery and used its Corplex(R) technology to develop the first and only once-weekly transdermal patch for the treatment of Alzheimer's Disease - Adlarity(R). We are presently seeking commercial partnerships on several internally-developed brand...

Corium offers full development and commercial manufacture for generic prescription transdermal systems - presently manufacturing Clonidine TDS (US market). We have several other products under development for licensing or can work with partners on their selected product opportunities.